Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06608134 · ClinicalTrials.gov registry record · Early Phase 1
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis
A Early Phase 1 study of Osteoarthritis, Knee, sponsored by R3 Medical Research.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 120
- Enrollment target
- 5
- Study locations
NCT06608134 is a Early Phase 1 study of Osteoarthritis, Knee that is actively recruiting participants, run by R3 Medical Research. The registered enrollment target is 120 participants, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (79% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT06608134, a Early Phase 1 study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by R3 Medical Research.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 120 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of three dosing treatment arms that will consist of one intra-articular knee injection containing either low dose, medium dose or high dose WJ allograft tissue.
Conditions Studied
Interventions
- BIOLOGICAL Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection
Study Locations (5)
California
- R3 Anti Aging Beverly Hills - Beverly Hills
- Optimal Medical Group - Fresno
Arizona
- R3 Anti Aging Scottsdale - Scottsdale
New York
- Scheer Medical Wellness - New York
Texas
- Dr. Duc (Steve) Le, MD - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2029-10-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06608134
The ClinicalTrials.gov registry entry for NCT06608134 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 579-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (79% lower). The listed sponsor is R3 Medical Research, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection is the first listed.
NCT06608134 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Arizona, New York.
Frequently Asked Questions
What is clinical trial NCT06608134 about?
NCT06608134 is a clinical study titled "Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis". This is a Pilot Study which is randomized, prospective, open label, dose escalation, non-controlled evaluating safety and feasibility of intra-articular Wharton's Jelly (WJ) allograft will be evaluated in patients suffering with knee osteoarthritis. The participants will be randomized to one of thre...
What is the current status of trial NCT06608134?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 120 participants. The study started on 2024-10-01. Estimated completion is 2029-10-01.
What conditions does trial NCT06608134 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT06608134?
The interventions under investigation include: Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT06608134?
This trial is sponsored by R3 Medical Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06608134 being conducted?
This trial has 5 study locations across Arizona, California, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.